About Bausch Health
Bausch Health is a company based in Laval (Canada) founded in 1960. The company has 20,700 employees as of December 31, 2024. Bausch Health has completed 19 acquisitions, including Aton Pharma, Bausch & Lomb and DURECT. Bausch Health offers products and services including Gastrointestinal Products, Dermatology Products, and Vision Care Products. Bausch Health operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.
- Headquarter Laval, Canada
- Employees 20700 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bausch Health Companies Inc.
-
Annual Revenue
$9.17 B (USD)11.56as on Dec 31, 2024
-
Net Profit
-$43.8 M (USD)92.11as on Dec 31, 2024
-
EBITDA
$2.97 B (USD)10.61as on Dec 31, 2024
-
Latest Funding Round
$500 M (USD), Debt – Conventional
Mar 08, 2019
- Investors
-
Employee Count
20700
as on Dec 31, 2024
-
Investments & Acquisitions
Aton Pharma
& 18 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bausch Health
Bausch Health is a publicly listed company on the TSX with ticker symbol BHC in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bausch Health
Bausch Health offers a comprehensive portfolio of products and services, including Gastrointestinal Products, Dermatology Products, and Vision Care Products.
Treats gastrointestinal disorders with innovative medications.
Provides solutions for skin conditions and aesthetic treatments.
Offers eye care solutions including devices and pharmaceuticals.
People of Bausch Health
Unlock access to complete
Software Development Team
152 people
Leadership Team
84 people
Sales and Marketing
62 people
Finance and Accounting
42 people
Senior Team
28 people
Legal and Compliance
24 people
Human Resources and Administration
17 people
Operations Team
17 people
Unlock access to complete
Funding Insights of Bausch Health
Investors in Bausch Health
Bausch Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ValueAct Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm based out of USA
|
Locked | Locked | Locked |
Investor details for Bausch Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bausch Health
Bausch Health has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Aton Pharma, Bausch & Lomb and DURECT.
Investment portfolio details for Bausch Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of an augmented reality marketing platform
|
Locked | Locked | 2015 | Locked | |
|
Drugs for hypoactive sexual desire disorder in women are developed.
|
Locked | Locked | 2011 | Locked | |
|
Pharmaceuticals and food supplements are manufactured and distributed.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Bausch Health
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Bausch Health
Detailed financials for Bausch Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bausch Health Comparisons
Peer comparison for Bausch Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bausch Health
Bausch Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| Locked | Locked | Locked |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
Detailed competitors of Bausch Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bausch Health
Complete news archive for Bausch Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bausch Health
Bausch Health was founded in 1960 and raised its 1st funding round 42 years after it was founded.
Bausch Health is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.
Joseph Papa is the current CEO of Bausch Health.
As of Dec 31, 2024, the latest employee count at Bausch Health is 20,700.
Annual revenue of Bausch Health is $9.17B as on Dec 31, 2024.
Founded in 1960 and headquartered in Laval, Canada, operations focus on the pharmaceutical sector where therapeutics are developed for conditions in dermatology, gastrointestinal disorders, eye health, neurology, and other areas. Products such as the lead candidate IDP-120 for acne treatment are manufactured. In 2023, annual revenues of 8.15 billion were recorded alongside a net loss of 0.36 billion.
Bausch Health's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Bausch Health offers Gastrointestinal Products, Dermatology Products, and Vision Care Products.
Yes, Bausch Health is publicly traded on TSX under the ticker symbol BHC.
Bausch Health has made 19 acquisitions, including Aton Pharma, Bausch & Lomb, and DURECT.
Bausch Health has 1 investor. Key investors include ValueAct Capital.
The ticker symbol of Bausch Health is BHC on TSX.